January 26, 2018April 27, 2018

Phase 1 Trial of Curis and Aurigene’s Second Lymphoma Therapy is Underway

News

The first patient in a Phase 1 clinical trial of Curis and Aurigene’s oral lymphoma therapy has begun receiving it. CA-4948 is the second therapy from the partnership to reach clinical trials. It works by ... Read more

September 7, 2017

Verastem, with Phase 3 Results, to Request FDA Approve Oral Duvelisib to Treat Advanced CLL and SLL

News

Verastem’s duvelisib was seen to outperform Arzerra (ofatumumab) in a Phase 3 trial of patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), the company announced. ... Read more